NFKB1 and acute kidney injury: As shown in Figure 15, anisodamine hydrobromide inhibits NF-κB signaling, thereby inhibiting LPS-induced apoptosis and inflammation [88], and alleviates LPS-induced acute kidney failure by inhibiting mitochondrial dysfunction and oxidative stress [87].